-
Published23/10/2025
-
Deadline24/11/2025
-
Awarded12/01/2026
-
Today14/05/2026
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
Medicinal products containing the active substance PANITUMUMAB
The subject of the public contract is the continuous supply of medicinal products containing the active substance Panitumumab with a strength of 20 mg/ml in the form of a concentrate for solution for infusion in a 5 ml vial. Continuous deliveries of medicinal products will be made on the basis of partial orders issued according to the customer's current needs for a period of two years from the date of entry into force of the Purchase Agreement. In detail in the tender documentation.
https://nen.nipez.cz/portal/client/?zp=N006-25-V00035684
https://nen.nipez.cz/portal/client/?zp=N006-25-V00035684
33600000 - Pharmaceutical products
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.